About Q-Vant Biosciences Q-Vant is a privately held biosciences company that has solved the supply chain problem of QS-21 and other Quillaja-based saponin adjuvants for the global human and animal ...

QS-21 is currently being evaluated as an adjuvant for many different vaccine candidates, both by itself as well as in combination with other immunostimulatory components. QS-21 is in clinical ...

TQL-1055 is a rationally designed, semi-synthetic analogue of the QS-21 saponin adjuvant, which is used in the currently available shingles vaccine. Saponin adjuvants are potent immune stimulators ...